| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |